Although many of the terms in a ‘nurse’ word cloud may hint at the broad job description (care, diligence, compassion etc), I ...

AC Immune SA has announced peer-reviewed results from its phase 1b/2a trial of two Tau-targeting active immunotherapies for early Alzheimer’s disease. The study compared ACI-35.030, developed with AC ...

Acella Pharmaceuticals and Neuvosyn Laboratories have announced positive topline results from a phase 2 clinical trial of ...

BlueRock Therapeutics has dosed the first patient in its pivotal phase 3 trial of bemdaneprocel, an investigational cell ...

Nxera Pharma and Cancer Research UK have announced the first patient has been dosed in a phase 2a trial of HTL0039732, an ...

Tezspire (tezepelumab) has received a positive opinion from the CHMP for the treatment of chronic rhinosinusitis with nasal ...

Johnson & Johnson has announced a positive opinion from the CHMP recommending expanded marketing authorisation for TREMFYA ...

Xeltis has announced successful results from its aXess EU phase 3 trial, confirming the potential of its restorative vascular ...

Three new studies have launched in Manchester to evaluate the effectiveness of vaccines for severe acute respiratory ...

Modus Therapeutics will present new research on sevuparin for chronic kidney disease (CKD) with anemia at the 32nd Symposium ...

The European Commission has approved ROMVIMZA (vimseltinib) for adult patients with symptomatic tenosynovial giant cell ...

Among patients with HS, HiSCR75, HiSCR90 and HiSCR100 responses seen at one year were sustained and improved to three years ...